Interaction of tumor cells with the microenvironment

Cell Communication and Signaling

Volumn 9, Issue , 2011, Pages

  Ungefroren, Hendrik ^a   Sebens, Susanne ^b   Seidl, Daniel ^a   Lehnert, Hendrik ^a   Hass, Ralf ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

cancer associated fibroblast; cell migration; epithelial to mesenchymal transition; extracellular matrix; mammary adenocarcinoma; metastasis; pancreatic ductal adenocarcinoma; tumor stroma; tumor associated macrophage

Indexed keywords

FOCAL ADHESION KINASE 1; GELATINASE B; INTEGRIN; INTERLEUKIN 1BETA; MATRILYSIN; SEMAPHORIN; SEMAPHORIN 4D; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; CARCINOGENESIS; CELL EXPANSION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GLYCOSYLATION; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STROMA; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 80052668582     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-9-18     Document Type: Review

References (61)

1. The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. J Brábek, CT Mierke, D Rösel, P Veselý B Fabry, Cell Commun Signal 2010 8 22 10.1186/1478-811X-8-22 20822526
2. Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. L Calorini, F Bianchini, Cell Commun Signal 2010 8 24 20822533
3. A tense situation: forcing tumour progression. DT Butcher, T Alliston, VM Weaver, Nat Rev Cancer 2009 9 108 122 10.1038/nrc2544 19165226
4. Matrix crosslinking forces tumor progression by enhancing integrin signaling. KR Levental, H Yu, L Kass, JN Lakins, M Egeblad, JT Erler, SF Fong, K Csiszar, A Giaccia, W Weninger, et al. Cell 2009 139 891 906 10.1016/j.cell.2009.10.027 19931152
5. beta1 integrin as a molecular therapeutic target. N Cordes, CC Park, Int J Radiat Biol 2007 83 753 760 10.1080/09553000701639694 18058364 (Pubitemid 350219108)
6. Integrins: Molecular targets in cancer therapy. GC Tucker, Curr Oncol Rep 2006 8 96 103 10.1007/s11912-006-0043-3 16507218
7. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. SL Payne, B Fogelgren, AR Hess, EA Seftor, EL Wiley, SF Fong, K Csiszar, MJ Hendrix, DA Kirschmann, Cancer Res 2005 65 11429 11436 10.1158/0008-5472.CAN-05-1274 16357151 (Pubitemid 41821700)
8. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. DC Radisky, DD Levy, LE Littlepage, H Liu, CM Nelson, JE Fata, D Leake, EL Godden, DG Albertson, MA Nieto, et al. Nature 2005 436 123 127 10.1038/nature03688 16001073 (Pubitemid 40966197)
9. Lysyl oxidase mediates hypoxic control of metastasis. JT Erler, AJ Giaccia, Cancer Res 2006 66 10238 10241 10.1158/0008-5472.CAN-06-3197 17079439 (Pubitemid 44799737)
10. Lysyl oxidase as a potential therapeutic target. C Rodríguez, A Rodríguez-Sinovas, J Martínez-González, Drug News Perspect 2008 21 218 224 10.1358/dnp.2008.21.4.1213351 18560621
11. Collective cell migration in morphogenesis, regeneration and cancer. P Friedl, D Gilmour, Nat Rev Mol Cell Biol 2009 10 445 457 10.1038/nrm2720 19546857
12. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. N Takebe, RQ Warren, SP Ivy, Breast Cancer Res 2011 13 211 10.1186/bcr2876 21672282
13. Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcinoma? HG Hotz, B Hotz, HJ Buhr, Anticancer Agents Med Chem 2011 11 448 454 21492078
14. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. T Arumugam, V Ramachandran, KF Fournier, H Wang, L Marquis, JL Abbruzzese, GE Gallick, CD Logsdon, DJ McConkey, W Choi, Cancer Res 2009 69 5820 5828 10.1158/0008-5472.CAN-08-2819 19584296
15. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. S Ansieau, J Bastid, A Doreau, AP Morel, BP Bouchet, C Thomas, F Fauvet, I Puisieux, C Doglioni, S Piccinin, et al. Cancer Cell 2008 14 79 89 10.1016/j.ccr.2008.06.005 18598946 (Pubitemid 351890463)
16. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. CD May, N Sphyris, KW Evans, SJ Werden, W Guo, SA Mani, Breast Cancer Res 2011 13 202 21392411
17. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. MW Klymkowsky, P Savagner, Am J Pathol 2009 174 1588 1593 10.2353/ajpath.2009.080545 19342369
18. Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. S Giampieri, S Pinner, E Sahai, Cancer Res 2010 70 3435 3439 10.1158/0008-5472.CAN-10-0466 20424121
19. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. S Tsutsui, K Yasuda, K Suzuki, K Tahara, H Higashi, S Era, Oncol Rep 2005 14 425 431 16012726
20. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. H Kurahara, H Shinchi, Y Mataki, K Maemura, H Noma, F Kubo, M Sakoda, S Ueno, S Natsugoe, S Takao, J Surg Res 2011 167 211 219 10.1016/j.jss.2009.05.026 19765725
21. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. RD Leek, CE Lewis, R Whitehouse, M Greenall, J Clarke, AL Harris, Cancer Res 1996 56 4625 4629 8840975 (Pubitemid 26338061)
22. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. RD Stout, SK Watkins, J Suttles, J Leukoc Biol 2009 86 1105 1109 10.1189/jlb.0209073 19605698
23. Macrophage polarization in tumour progression. A Sica, P Larghi, A Mancino, L Rubino, C Porta, MG Totaro, M Rimoldi, SK Biswas, P Allavena, A Mantovani, Sem Cancer Biol 2008 18 349 355 10.1016/j.semcancer.2008.03.004
24. Macrophage activation and polarization. FO Martinez, A Sica, A Mantovani, M Locati, Front Biosci 2008 13 453 461 10.2741/2692 17981560 (Pubitemid 351599757)
25. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. P Allavena, A Sica, C Garlanda, A Mantovani, Immunol Rev 2008 222 155 161 10.1111/j.1600-065X.2008.00607.x 18364000 (Pubitemid 351430369)
26. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. J Condeelis, JW Pollard, Cell 2006 124 263 266 10.1016/j.cell.2006. 01.007 16439202 (Pubitemid 43121975)
27. Macrophage diversity enhances tumor progression and metastasis. BZ Qian, JW Pollard, Cell 2010 141 39 51 10.1016/j.cell.2010.03.014 20371344
28. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. JB Wyckoff, Y Wang, EY Lin, JF Li, S Goswami, ER Stanley, JE Segall, JW Pollard, J Condeelis, Cancer Res 2007 67 2649 2656 10.1158/0008-5472.CAN-06-1823 17363585 (Pubitemid 46548952)
29. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. SB Coffelt, R Hughes, CE Lewis, Biochim Biophys Acta 2009 1796 11 18 19269310
30. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. A Rigo, M Gottardi, A Zamò P Mauri, M Bonifacio, M Krampera, E Damiani, G Pizzolo, F Vinante, Mol Cancer 2010 9 273 10.1186/1476-4598-9-273 20946648
31. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. WH Yu, JF Woessner Jr, JD McNeish, I Stamenkovic, Genes Dev 2002 16 307 323 10.1101/gad.925702 11825873 (Pubitemid 34111411)
32. Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. C Bertram, R Hass, Mech Ageing Dev 2009 130 657 669 10.1016/j.mad.2009.08.001 19682489
33. Epidermal growth factor receptor regulates pancreatic fibrosis. SA Blaine, KC Ray, KM Branch, PS Robinson, RH Whitehead, AL Means, Am J Physiol Gastrointest Liver Physiol 2009 297 434 441 10.1152/ajpgi.00152.2009 19608732
34. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. CC Lynch, T Vargo-Gogola, MD Martin, B Fingleton, HC Crawford, LM Matrisian, Cancer Res 2007 67 6760 6767 10.1158/0008-5472.CAN- 07-0026 17638887 (Pubitemid 47105523)
35. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. E McIntyre, E Blackburn, PJ Brown, CG Johnson, WJ Gullick, Breast Cancer Res Treat 2010 122 105 110 10.1007/s10549-009-0536-5 19760033
36. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. X Lu, Q Wang, G Hu, C Van Poznak, M Fleisher, M Reiss, J Massague, Y Kang, Genes Dev 2009 23 1882 1894 10.1101/gad.1824809 19608765
37. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. I Majore, P Moretti, R Hass, C Kasper, Cell Commun Signal 2009 7 6 10.1186/1478-811X-7-S1-A6 19302702
38. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. A Lavrentieva, I Majore, C Kasper, R Hass, Cell Commun Signal 8 18
39. Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. S Chaturvedi, R Hass, Mech Aging Dev 2011 132 213 219 10.1016/j.mad.2011.04.002 21507328
40. Reconstruction of functionally normal and malignant human breast tissues in mice. C Kuperwasser, T Chavarria, M Wu, G Magrane, JW Gray, L Carey, A Richardson, RA Weinberg, Proc Natl Acad Sci USA 2004 101 4966 4971 10.1073/pnas.0401064101 15051869 (Pubitemid 38469186)
41. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. S Parrinello, JP Coppe, A Krtolica, J Campisi, J Cell Sci 2005 118 485 496 10.1242/jcs.01635 15657080 (Pubitemid 40310116)
42. The urokinase receptor as a potential target in cancer therapy. J Romer, BS Nielsen, M Ploug, Curr Pharm Des 2004 10 2359 2376 10.2174/1381612043383962 15279614 (Pubitemid 38855042)
43. Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic. AP Mazar, RW Ahn, TV O'Halloran, Curr Pharm Des 2011
44. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. M Shimoda, KT Mellody, A Orimo, Semin Cell Dev Biol 2010 21 19 25 10.1016/j.semcdb.2009.10.002 19857592
45. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. B Cat, D Stuhlmann, H Steinbrenner, L Alili, O Holtkötter, H Sies, P Brenneisen, J Cell Sci 2006 119 2727 2738 10.1242/jcs.03011 16757516 (Pubitemid 44184009)
46. Enhanced macromolecule diffusion deep in t umors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin. M Magzoub, S Jin, AS Verkman, FASEB J 2008 22 276 284 17761521
47. Cancer associated fibroblasts exploit reactive oxygen species through a pro-inflammtory signature leading to EMT and stemness. E Giannoni, F Bianchini, L Calorini, P Chiarugi, Antioxid Redox Signal 2011
48. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. A Orimo, PB Gupta, DC Sgroi, F Arenzana-Seisdedos, T Delaunay, R Naeem, VJ Carey, AL Richardson, RA Weinberg, Cell 2005 121 335 348 10.1016/j.cell.2005.02.034 15882617 (Pubitemid 40692295)
49. VEGF regulates PCB 104-mediated stimulation of permeability and transmigration of breast cancer cells in human microvascular endothelial cells. SY Eum, YW Lee, B Hennig, M Toborek, Exp Cell Res 2004 296 231 244 10.1016/j.yexcr.2004.01.030 15149853 (Pubitemid 38624644)
50. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. LS Ojalvo, CA Whittaker, JS Condeelis, JW Pollard, J Immunol 2010 184 702 712 10.4049/jimmunol.0902360 20018620
51. TGF-β signaling in breast cancer cell invasion and bone metastasis. Y Drabsch, P ten Dijke, J Mammary Gland Biol Neoplasia 2011 16 97 108 10.1007/s10911-011-9217-1 21494783
52. Basics of TGF-beta and pancreatic cancer. MJ Truty, R Urrutia, Pancreatology 2007 7 423 435 10.1159/000108959 17898532 (Pubitemid 47587621)
53. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. S Jones, X Zhang, DW Parsons, JC Lin, RJ Leary, P Angenendt, P Mankoo, H Carter, H Kamiyama, A Jimeno, et al. Science 2008 321 1801 1806 10.1126/science.1164368 18772397
54. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells. H Ungefroren, S Sebens, S Groth, F Gieseler, F Fändrich, Int J Oncol 2011 38 797 805 21225226
55. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF-β1 haploinsufficiency. J Pandey, SM Umphress, Y Kang, J Angdisen, A Naumova, KL Mercer, T Jacks, SB Jakowlew, Carcinogenesis 2007 28 2589 2596 10.1093/carcin/bgm136 17690114 (Pubitemid 350238962)
56. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic adenocarcinoma cells: Control by Rac1. H Ungefroren, S Groth, S Sebens, H Lehnert, F Gieseler, F Fändrich, Mol Cancer 2011 10 67 10.1186/1476-4598- 10-67 21624123
57. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor β1- and Slug-dependent: role in malignant transformation of pancreatic cancer. C Geismann, M Morscheck, D Koch, F Bergmann, H Ungefroren, A Arlt, MS Tsao, MG Bachem, P Altevogt, B Sipos, UR Fölsch, H Schäfer, SS Müerköster, Cancer Res 2009 69 4517 4526 10.1158/0008-5472.CAN-08- 3493 19435915
58. TGFbeta signalling: a complex web in cancer progression. H Ikushima, K Miyazono, Nat Rev Cancer 2010 10 415 424 10.1038/nrc2853 20495575
59. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? AR Tan, G Alexe, M Reiss, Breast Cancer Res Treat 2009 115 453 495 10.1007/s10549-008-0184-1 18841463
60. Targeting the transforming growth factor-β signaling pathway in human cancer. NS Nagaraj, PK Datta, Expert Opin Investig Drugs 2010 19 77 91 10.1517/13543780903382609 20001556
61. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. H Ungefroren, S Sebens, S Groth, F Gieseler, F Fändrich, Curr Cancer Drug Tar 2011 11 524 535 10.2174/156800911795538075